2026-2030年全球照護現場（POC）市場

全球即時診斷（POC）市場預計將從 2025 年到 2030 年成長至 141.434 億美元，預測期內複合年成長率為 8.2%。

本報告對全球即時診斷 (POC) 市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及對約 25 家公司的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括：分散式醫療檢測的普及、感染疾病和慢性病盛行率的上升以及診斷平台技術的不斷進步。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告包含歷史數據和預測數據。

本研究指出，多參數、多檢測平台的轉變是未來幾年全球即時診斷（POC）市場成長的關鍵促進因素之一。此外，診斷技術與數位健康生態系統的日益融合，以及分子檢測在即時診斷環境中的擴展，預計也將產生顯著的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球照護現場（POC）市場
• 產品細分市場分析，2020-2024 年
• 2020年至2024年最終用戶細分市場分析
• 2020-2024年基於平台的細分市場分析
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球照護現場（POC）市場
• 地緣政治衝突的影響：全球照護現場（POC）市場

第7章：五力分析

第8章 市場區隔：依產品

• 比較：按產品
• 感染疾病
• 血液學診斷
• 快速心血管疾病
• 快速凝固
• 其他
• 市場機會：依產品分類

第9章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 醫院和診所
• 居家照護環境
• 臨床診斷
• 市場機會：依最終用戶分類

第10章 市場區隔：依平台分類

• 比較：按平台
• 橫向流動化驗
• 分子診斷
• 其他
• 市場機會：依平台分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 印尼
  • 新加坡
• 世界其他地區（RoW）
  • 巴西
  • 澳洲
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 阿根廷
  • 哥倫比亞
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Abbott Laboratories
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• BioMerieux SA
• DiaSorin SpA
• F. Hoffmann La Roche Ltd.
• HORIBA Ltd.
• Meridian Bioscience Inc.
• Nova Biomedical Corp.
• QuidelOrtho Corp.
• Radiometer Medical ApS
• Siemens Healthineers AG
• Sysmex Corp.
• Thermo Fisher Scientific Inc.
• Werfenlife SA

第16章附錄

The global point of care (POC) diagnostics market is forecasted to grow by USD 14143.4 mn during 2025-2030, accelerating at a CAGR of 8.2% during the forecast period. The report on the global point of care (POC) diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expansion of decentralized healthcare testing, increasing prevalence of infectious and chronic diseases, continuous technological advancement in diagnostic platforms.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global point of care (POC) diagnostics market is segmented as below:

By Product

• Infectious disease
• Hematology diagnostics
• Rapid cardiovascular
• Rapid coagulation
• Others

By End-User

• Hospitals and clinics
• Homecare settings
• Clinical diagnostic

By Platform

• Lateral flow assays
• Molecular diagnostics
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the increasing shift toward multi-condition and multiplex testing platforms as one of the prime reasons driving the global point of care (POC) diagnostics market growth during the next few years. Also, growing integration of diagnostics with digital health ecosystems and expansion of molecular testing within point-of-care environments will lead to sizable demand in the market.

The report on the global point of care (POC) diagnostics market covers the following areas:

• Global point of care (POC) diagnostics market sizing
• Global point of care (POC) diagnostics market forecast
• Global point of care (POC) diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global point of care (POC) diagnostics market vendors that include Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., Biolytical Laboratories Inc., Biomedomics Inc., BioMerieux SA, Chembio Diagnostics Inc., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., HORIBA Ltd., Meridian Bioscience Inc., Nova Biomedical Corp., PTS Diagnostics, QuidelOrtho Corp., Radiometer Medical ApS, Sd Biosensor Inc., Sekisui Diagnostics LLC, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc, Werfenlife SA. Also, the global point of care (POC) diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Platform
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Point Of Care (POC) Diagnostics Market 2020 - 2024
  • Historic Market Size - Data Table on Global Point Of Care (POC) Diagnostics Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Platform segment analysis 2020 - 2024
  • Historic Market Size - Platform Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global point of care (POC) diagnostics market
• 6.2 Impact of geopolitical conflicts on global point of care (POC) diagnostics market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Infectious disease - Market size and forecast 2025-2030
• 8.4 Hematology diagnostics - Market size and forecast 2025-2030
• 8.5 Rapid cardiovascular - Market size and forecast 2025-2030
• 8.6 Rapid coagulation - Market size and forecast 2025-2030
• 8.7 Others - Market size and forecast 2025-2030
• 8.8 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals and clinics - Market size and forecast 2025-2030
• 9.4 Homecare settings - Market size and forecast 2025-2030
• 9.5 Clinical diagnostic - Market size and forecast 2025-2030
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Platform

• 10.1 Market segments
• 10.2 Comparison by Platform
• 10.3 Lateral flow assays - Market size and forecast 2025-2030
• 10.4 Molecular diagnostics - Market size and forecast 2025-2030
• 10.5 Others - Market size and forecast 2025-2030
• 10.6 Market opportunity by Platform
  • Market opportunity by Platform ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Singapore - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Australia - Market size and forecast 2025-2030
  • 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.4 UAE - Market size and forecast 2025-2030
  • 12.6.5 Israel - Market size and forecast 2025-2030
  • 12.6.6 South Africa - Market size and forecast 2025-2030
  • 12.6.7 Argentina - Market size and forecast 2025-2030
  • 12.6.8 Colombia - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Expansion of decentralized healthcare testing
  • Increasing prevalence of infectious and chronic diseases
  • Continuous technological advancement in diagnostic platforms
• 13.2 Market challenges
  • High regulatory complexity and approval variability
  • Supply chain and inventory management complexities
  • Limited access to POC diagnostics in developing nations
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Increasing shift toward multi-condition and multiplex testing platforms
  • Growing integration of diagnostics with digital health ecosystems
  • Expansion of molecular testing within point-of-care environments

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.6 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.7 BioMerieux SA
  • BioMerieux SA - Overview
  • BioMerieux SA - Business segments
  • BioMerieux SA - Key offerings
  • BioMerieux SA - Segment focus
  • SWOT
• 15.8 DiaSorin SpA
  • DiaSorin SpA - Overview
  • DiaSorin SpA - Business segments
  • DiaSorin SpA - Key news
  • DiaSorin SpA - Key offerings
  • DiaSorin SpA - Segment focus
  • SWOT
• 15.9 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.10 HORIBA Ltd.
  • HORIBA Ltd. - Overview
  • HORIBA Ltd. - Business segments
  • HORIBA Ltd. - Key offerings
  • HORIBA Ltd. - Segment focus
  • SWOT
• 15.11 Meridian Bioscience Inc.
  • Meridian Bioscience Inc. - Overview
  • Meridian Bioscience Inc. - Product / Service
  • Meridian Bioscience Inc. - Key offerings
  • SWOT
• 15.12 Nova Biomedical Corp.
  • Nova Biomedical Corp. - Overview
  • Nova Biomedical Corp. - Product / Service
  • Nova Biomedical Corp. - Key offerings
  • SWOT
• 15.13 QuidelOrtho Corp.
  • QuidelOrtho Corp. - Overview
  • QuidelOrtho Corp. - Business segments
  • QuidelOrtho Corp. - Key offerings
  • QuidelOrtho Corp. - Segment focus
  • SWOT
• 15.14 Radiometer Medical ApS
  • Radiometer Medical ApS - Overview
  • Radiometer Medical ApS - Product / Service
  • Radiometer Medical ApS - Key offerings
  • SWOT
• 15.15 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 15.16 Sysmex Corp.
  • Sysmex Corp. - Overview
  • Sysmex Corp. - Business segments
  • Sysmex Corp. - Key news
  • Sysmex Corp. - Key offerings
  • Sysmex Corp. - Segment focus
  • SWOT
• 15.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 15.18 Werfenlife SA
  • Werfenlife SA - Overview
  • Werfenlife SA - Product / Service
  • Werfenlife SA - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations